MORRISVILLE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) – Liquidia Corporation (Nasdaq: LQDA), a biopharmaceutical company driven by science and compassion to revolutionize care for patients with challenging respiratory and vascular diseases, announced today that it will report its third quarter 2026